Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133433-34-8

Post Buying Request

133433-34-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133433-34-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 133433-34-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,4,3 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 133433-34:
(8*1)+(7*3)+(6*3)+(5*4)+(4*3)+(3*3)+(2*3)+(1*4)=98
98 % 10 = 8
So 133433-34-8 is a valid CAS Registry Number.

133433-34-8Relevant articles and documents

Total Synthesis of the Chlorinated Indigo-N-Glycosides Akashin A, B and C

Pfretzschner, Alexander T.,Unverzagt, Carlo

supporting information, p. 206 - 229 (2021/03/22)

A total synthesis of the indigo-derived natural products akashin A-C was developed. The key step was the N-glycosylation of soluble N-benzylated-indigos with a suitably protected viosaminyl trichloroacetimidate. This donor was obtained from D-galactose. U

Indoxyl-based umpolung strategy for the synthesis of unsymmetrical 3,3′-biindoles

Guo, Jing,Weng, Jiang,Huang, Gong-Bin,Huang, Lin-Jie,Chan, Albert S.C.,Lu, Gui

supporting information, p. 5493 - 5496 (2016/11/19)

3,3′-Bisindoles are known to be important structural motifs found in bioactive natural products, pharmaceuticals, and functional materials. Herein, a novel indoxyl-based approach was established for the synthesis of unsymmetrical 3,3′-biindoles from indoles and indoxyls. This approach generated moderate to excellent yields of the desired products (24 examples, up to 98% yield). The present method features broad substrate scope, operational simplicity, high atom economy, and utilization of non-toxic and inexpensive molecular iodine as catalyst. The applicability of this method has been demonstrated by the facile gram-scale synthesis.

INDIRUBIN-3'-OXIME DERIVATIVES AS POTENT CYCLIN DEPENDENT KINASE INHIBITORS

-

Page/Page column 17, (2011/09/14)

The present invention relates to an indirubin-3'-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3'-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133433-34-8